Argenica Therapeutics LtdASX: AGN

Argenica Therapeutics: Results of Annual General Meeting

· Issued by Argenica Therapeutics Ltd via ASX

Filed with ASX · · 2 pages · English

Summary by 6ix AI

Argenica Therapeutics Ltd held its Annual General Meeting and all resolutions were passed by a poll. The filing provides details of the proxy votes and votes cast for each resolution. The resolutions included the adoption of the remuneration report and the re-election of a director. The results indicate strong support for the proposed resolutions from shareholders.

Written by 6ix AI from the company’s filing. How 6ix writes summaries

Release

ASX ANNOUNCEMENT RESULTS OF ANNUAL GENERAL MEETING Perth, Australia; 19 NOVEMBER 2026 – Argenica Therapeutics Limited (ASX: AGN) (“Argenica” or the “Company”) held its Annual General Meeting of Shareholders at 2.00 PM (WST) on 19 November 2026 and advises that all resolutions were passed...

Argenica Therapeutics Ltd on 6ix

Story so far

Earlier from Argenica Therapeutics

All Argenica Therapeutics news releases